TrialMedical oncology (Northwood, London, England)2014

Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy.

Soley Bayraktar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.